A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
Open Access
- 15 August 1996
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 335 (7), 462-467
- https://doi.org/10.1056/nejm199608153350702
Abstract
Uncontrolled studies suggest that a combination of chemotherapy and radiotherapy improves the survival of patients with esophageal adenocarcinoma. We conducted a prospective, randomized trial comparing surgery alone with combined chemotherapy, radiotherapy, and surgery.Keywords
This publication has 26 references indexed in Scilit:
- The Significance of c-erb B-2 and p53 Immunoreactivity in Patients with Adenocarcinoma of the EsophagusAnnals of Surgery, 1995
- Improved Survival with Neoadjuvant Therapy and Resection for Adenocarcinoma of the EsophagusAnnals of Surgery, 1993
- The rising trend in oesophageal adenocarcinoma and gastric cardiaEuropean Journal Of Cancer Prevention, 1992
- A pilot study of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagusCancer, 1991
- Rising incidence of adenocarcinoma of the esophagus and gastric cardiaPublished by American Medical Association (AMA) ,1991
- Treatment of adenocarcinoma of the cardia with synchronous chemotherapy and radiotherapyBritish Journal of Surgery, 1990
- Time-related changes in characteristics of prognostic significance in carcinomas of the oesophagus and cardiaBritish Journal of Surgery, 1989
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982
- Adenocarcinoma of the Gastric Cardia The Choice of GastrectomyAnnals of Surgery, 1980
- Autopsy Findings in Carcinoma of the EsophagusActa Radiologica: Oncology, Radiation, Physics, Biology, 1979